Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA
- PMID: 28049571
- DOI: 10.1016/S1470-2045(16)30653-2
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA
MeSH terms
Substances
LinkOut - more resources
Full Text Sources